Hillevax

Hillevax Net Debt / EBITDA

Delisted

The Net Debt to EBITDA of Hillevax (HLVX) as of Nov 20, 2026 is 1.10. In the previous year, Net Debt to EBITDA was 2.09 — a change of -47.14% (lower).

Net Debt / EBITDA

1.10

YoY

-47.14%

Last updated:

Net Debt to EBITDA of Hillevax is 2024 1.10 . Net Debt to EBITDA of Hillevax was 2023 2.09 . It decreases by -47.14% lower compared to the previous year.

The Hillevax Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2019
-0.79 USD
Jan 1, 2020
-1.96 USD
Jan 1, 2021
-0.63 USD
Jan 1, 2022
4.06 USD
Jan 1, 2023
2.09 USD
Jan 1, 2024
1.10 USD
The Hillevax Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
1.10-47.14%
2.09-48.61%
4.06-743.59%
-0.63-67.85%
-1.96+150.11%
-0.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

Net Debt to EBITDA of Hillevax is 1.10 in 2024.

Net Debt to EBITDA of Hillevax changed from 2.09 to 1.10, representing a -47.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Hillevax since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Hillevax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hillevax

All Key Metrics — Hillevax